Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Provided By GlobeNewswire
Last update: Nov 12, 2025
NORWOOD, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage oncology and obesity company, today provided a corporate update and reported financial results for the quarter ended September 30, 2025.
Read more at globenewswire.com
